Results 51 to 60 of about 57,710 (262)
Efficacy of Low-Dose Fluconazole for Primary Prophylaxis of Invasive Candida Infections in Patients With Acute Leukemia: A Double-Blind Randomized Clinical Trial. [PDF]
ABSTRACT Background Invasive fungal infections (IFIs), particularly Candida infections, are a significant cause of morbidity and mortality in patients with acute leukemia. While fluconazole is widely used for prophylaxis, the optimal dosing regimen remains uncertain.
Savary-Kouzehkonan R+7 more
europepmc +2 more sources
ABSTRACT Objective This study aimed to analyze the outcomes of clinical management of patients with interstitial cystitis (IC). Patients and Methods We retrospectively analyzed the electronic medical records of patients with IC who visited outpatient clinics with pelvic pain between October 2005 and December 2019.
Hyun Ju Jeong+4 more
wiley +1 more source
Background The most common adverse event in oral lichen planus (OLP) patients undergoing topical corticosteroid therapy is opportunistic infection with oral Candida.
Auranat Prachayakul+3 more
doaj +1 more source
ABSTRACT Artificial Intelligence (AI)‐based applications have significant potential to differentiate between pressure injuries (PI) and incontinence‐associated dermatitis (IAD), common challenges in nursing practice. Within the KIADEKU overall project, we are developing an AI‐based application to aid in the nursing care of PI and IAD and to facilitate ...
Hannah Pinnekamp+8 more
wiley +1 more source
Immunomodulation as Therapy for Fungal Infection: Are We Closer?
Invasive fungal disease (IFD) causes significant morbidity in immunocompromised patients due to their weakened immune system. Immunomodulatory therapy, in synergy with existing antifungal therapy, is an attractive option to enhance their immune system ...
Qi Hui Sam+11 more
doaj +1 more source
Risk of candidiasis associated with interleukin-17 inhibitors: Implications and management
The application of interleukin-17 (IL-17) inhibitors, including secukinumab, ixekizumab, brodalumab, and bimekizumab, are associated with elevated risk of candidiasis. These medications interfere with the IL-17 pathway, which is essential for maintaining
Hazrat Bilal+17 more
doaj +1 more source
A mitochondria‐targeted AIE photosensitizer, LIQ‐TPA‐TZ, was developed to fight against Candida infection. It can efficiently produce reactive oxygen species to kill Candida guilliermondii and eradicate biofilms. It not only disrupted the respiratory chain and affected the metabolism and energy supply but also reduced the fungi adhesion and filament ...
Kun‐Mei Liu+5 more
wiley +1 more source
Abstract Secukinumab is one of the human monoclonal antibodies recommended in the Japanese guidelines for patients with psoriasis, but few case reports and clinical studies on secukinumab for pustular psoriasis are available because of the rarity of the disease.
Ayako Fujishige, Noriko Seko
wiley +1 more source
Rational treatment for vulvovaginal candidiasis caused by resistant Candida species [PDF]
G.B. Dikke F.I. Inozemtsev Academy of Medical Education, St. Petersburg, Russian Federation In recent decade, growing incidence (24–29%) of vulvovaginal candidiasis caused by Candida non-albicans is reported.
G.B. Dikke
doaj